Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them.
More specific conditions that are subtypes of Autoantibodies in the MeSH hierarchy.
5 drugs (4 approved, 1 experimental)
Phase 4 trials (3)
Phase 2 trials (1)